INTRODUCTION
Many formerly premature infants being discharged from neonatal intensive care units continue to have frequent apnea. 1 The long-term significance of this is uncertain; there does not seem to be an increased risk of sudden unexpected death or apparent lifethreatening events in such infants, but the studies investigating this potential link have had limited power to detect small but clinically significant increases in risk. 1, 2 The persistence of apnea at discharge does, however, seem to be associated with an increase in neurodevelopmental disability. 3 Many premature infants experience frequent and prolonged acid gastro-esophageal reflux (g-e reflux), which may also persist until discharge. 4 However, g-e reflux is a near-universal phenomenon in the newborn infant, and it is unclear at what point reflux should be considered pathological. The overall clinical impact of g-e reflux in the preterm infant is uncertain. Attempts to clarify the situation have mostly involved retrospective identification of infants with reflux from diagnoses recorded in hospital databases, 5, 6 which is likely to be very unreliable information. Recent practice has often depended on the clinical assumption that g-e reflux may be the underlying cause of apnea in some infants, 7 despite two previous studies which have not been able to demonstrate a relationship. 8, 9 Routine evaluation for either apnea or g-e reflux prior to discharge of the formerly preterm infant is also of uncertain value.
We performed the present study to determine the incidence of g-e reflux during predischarge apnea evaluations in preterm infants at a single institution. The hypothesis of the study was that preterm infants with frequent apnea persisting until discharge would have an increased frequency of reflux episodes during continuous esophageal pH monitoring.
METHODS
Infants of less than or equal to 32 weeks' gestation, born between July 1997 and August 1998, were considered for enrolment from the 154 eligible infants studied during this period. Infants were enrolled when they were thought to be within 3 days of hospital discharge, and were clinically thought to be apnea-free. Following informed parental consent, a 12-hour cardiorespirogram was performed with continuous esophageal pH monitoring. The cardiorespirogram methodology consisted of airflow monitoring by thermistor for diagnosis of obstructive apnea, as well as heart rate, chest movement by impedance and pulse oximeter. The signals were digitized and recorded at a rate of four samples per second and downloaded onto a personal computer when completed. Tracings were analyzed by a semi-automated system (Edentrace, Mallinkrodt) and reviewed by a
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To determine the relationship between respiratory patterns and acid gastroesophageal reflux ( g -e reflux ) prior to discharge of the formerly preterm infant.
STUDY DESIGN:
Forty -five infants of < 32 weeks' gestation were studied at an average postmenstrual age of 37.2 weeks ( SD 3.5 ). Following informed parental consent, a 12 -hour multichannel recording including esophageal pH was obtained. Apneas of greater than 10 seconds were recorded, as well as the occurrence of bradycardia or desaturation.
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Acid g -e reflux ( pH < 4.0 ) occurred at least once in all of the infants; prevalence was between < 1% and 41% of the 12 -hour record ( median 4.6%, interquartile range 0.5% to 9% ). The number of reflux episodes ranged from 1 to 143 ( median 23 ). The number of apneas ( > 10 seconds duration ) ranged from 0 to 71, median 6. There was no correlation between apnea frequency or severity and reflux frequency or duration. There was no difference in apnea frequencies between the 5 minutes after the start of a reflux episode and the 5 minutes prior to each episode.
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technician. Apneas of greater than 10 seconds were recorded, as well as the occurrence of bradycardia (to less than 100 beats/min for greater than 5 seconds) or desaturation (to less than 85% for greater than 10 seconds). The duration of each apneic spell was recorded and the lowest saturation and heart rate obtained for each apnea. An antimony pH probe was used, and connected to a standard pH amplifier (Medtronics, Minneapolis), which interfaced to the Edentrace recording system. Positioning of the pH probe, at the junction of the mid-and lower thirds of the esophagus, was confirmed by chest x-ray, the probe was calibrated prior to each usage, to a pH of 1.0 and a pH of 7.0. During recording, infant's care was not altered, breast milk or formula feeds were continued, and apple juice feeds were not used. Infants were usually nursed side lying with the head of the bed elevated 158 to 208. None of these infants was on cisapride or any other pharmacological therapies for g-e reflux or increased acidity at the time of the study. G-e reflux was diagnosed when the esophageal pH fell to less than 4.0. Reflux was quantified by the number of individual episodes of reflux, the length of each episode of g-e reflux and the total duration of reflux during the 12-hour study. We analyzed the traces to determine whether apnea was more common during the 5 minutes after the start of a reflux episode compared with during the 5 minutes prior to each episode.
We did not require any follow up as part of this study, in view of our previous observations that infants with predischarge apnea did not fare any worse than infants with little or no apnea. 1 The study was approved by the IRB of the University of California, San Diego Medical Center Ethical Review Committee.
Correlations between apnea frequency and duration and acid g-e reflux frequency and duration were sought using Pearson's correlation coefficient. A significance cut-off of 0.05 was used for all correlations. To determine whether apneas were more frequent immediately prior to or immediately after the start of reflux, a Mann-Whitney rank sum test was used.
RESULTS
Forty-five infants with a mean birth weight of 1354 g (SD 650) and gestational age at birth of 30 weeks (SD 3.1) were studied at an average postmenstrual age of 37.1 weeks (SD 3.5). The pH monitoring demonstrated acid g-e reflux (pH <4.0) on at least one occasion in all of the infants. Prevalence of reflux was between <1% and 41% of the 12-hour record, with a median of 4.6% (interquartile range 0.5% to 9%). The number of reflux episodes ranged from 1 to 143 (median 23, interquartile range 6 to 44) and the duration of the individual events ranged from 1 to 84 minutes, median 8.1 minutes (interquartile range 2.1 to 16.6 minutes). The number of apneas ( >10 seconds duration) ranged from 0 to 71, median 6 (interquartile range 0 to 20) in the 12-hour study. There was no significant correlation between apnea frequency and g-e reflux frequency (r=0.28, p=NS; Figure 1 ), nor between apnea frequency and g-e reflux duration (r=0.18, p=NS). There was no significant correlation between the number of apneas with desaturation and the frequency of reflux (r=0.18, p=NS), nor between the number of apneas with bradycardia and the frequency of reflux (r=0.06, p=NS; Figure 2 ). These results held true for all apneas and when analyzed for only mixed and obstructive apneas, which are sometimes thought to be more likely to be associated with reflux. The correlation coefficient for the relationship between mixed and obstructive apnea frequency and the frequency of g-e reflux was r=0.37, p=NS. We repeated the analyses by restricting the included spells to longer apneas ( >15 seconds). This had no effect on the results; there remained no significant correlation between apnea frequency and g-e reflux frequency (r=0.17, p=NS; Figure 3 ) or duration (r=0.09, p=NS).
Ten infants were receiving theophylline at the time of the study; these infants had more apneic spells than the infants not receiving theophylline, but this was not statistically significant. They also had more episodes of g-e reflux, which were longer on average than the nontheophylline-receiving infants, to give a total g-e reflux time that was significantly greater among the theophylline-receiving infants than the no-theophylline infants (see Table 1 ).
There was no difference in apnea frequencies between the two time periods immediately before, and immediately after, reflux commencement. In the 5 minutes prior to a reflux episode, there was a mean of 0.08 apneas (range 0 to 0.72) per epoch; after the start of a reflux episode, there was a mean of 0.1 apneas (range 0 to 0.51) per 5-minute epoch (difference not significant).
DISCUSSION
G-e reflux is extremely common in newborn infants. This is presumed to be because of maturational inadequacies in motor control of the stomach and gastro-esophageal junction, with increased esophageal and decreased gastric compliance. 10 Lower esophageal relaxations are no more frequent than they are in adults, but the different secondary response to lower esophageal relaxation leads to clinical regurgitation and ''spitting up''. 10 The usual liquid diet of the infant and prevalence of recumbent position are also important factors. 11 The methodology used in the current study can only, of course, detect reflux of acidic gastric contents into the mid esophagus. Reflux of nonacid fluid would have been undetected and may be very common, potentially much more common than acid reflux, particularly in infants receiving feeds of either breast milk or formula, 12 as both are good buffers of gastric acid. Reflux of nonacid fluid is currently difficult or impossible to diagnose with prolonged or continuous recording. The new multi-impedance technique of Skopnik et al. 12 may in the future allow much better determination of the true incidence and clinical sequelae of g-e reflux. The true prevalence of g-e reflux in preterm infants of differing gestational and postnatal ages will require further work and improved technology.
Group studies such as this one cannot determine whether occasional infants may have significant clinical sequelae, including apnea, associated with reflux. Indeed, we believe it is likely that there are, in fact, occasional infants who experience apnea as a response to g-e reflux; 13 it seems unlikely, however, from this study and others that g-e reflux contributes significantly to the overall frequency of apnea in preterm infants. 8, 9 Indeed, although associations between g-e reflux and a variety of adverse clinical outcomes have been postulated, 6 there is little good evidence of frequent harm associated with this phenomenon. 5 In spite of the lack of such evidence, there is currently an epidemic of treatment of preterm infants 7 with untested, probably ineffective 14, 15 and potentially toxic agents, 16 such as cisapride. There is even doubt about whether this particular agent has any pro-kinetic activity in the preterm infant. 17 G-e reflux, from the data presented herein and other recently published information, 18 is a near-universal phenomenon in the preterm infant. Rather than treating a huge proportion of preterm infants with measures aimed at reducing reflux, we should rather be investigating under what clinical circumstances reflux is associated with clinical sequelae. Only then can we design prospective studies to ascertain whether anti-reflux measures improve those clinical indicators with an acceptable risk profile.
There are a small number of studies which appear to show a relationship between apnea and g-e reflux. For example, Marino 4 showed an increase in apnea frequency in infants who had g-e reflux. However, in that study, the pH recording was only continued for 1 hour, while the respiratory recording duration was 13 hours total. Furthermore, the authors divided the infants into those with and ''without'' reflux using an arbitrary criterion of 10% of the study time having an esophageal pH less than 4. We did not find that this cut off had any implications among the 11 infants with more than 10% reflux; the incidence of apnea was very similar to those with less reflux.
Methylxanthines are frequently stated to be associated with an increased incidence of g-e reflux. The xanthine used in our unit for the majority of infants at the time of the study, theophylline, was associated with an increased number of reflux episodes and no change in the average duration of each episode. Although in adults it is clear that xanthines may relax the lower esophageal sphincter, there is remarkably little information regarding the influence of xanthine therapy on reflux in the newborn infant. 19 -21 The results of the current study would support a potential effect of xanthines increasing g-e reflux.
This study confirms our previous investigations, which have demonstrated that many preterm infants continue to have apnea when otherwise ready for hospital discharge. 1, 3, 22 Whether there are any long-term sequelae from predischarge apnea is uncertain. There is a statistical association, as mentioned above, between predischarge apnea and poorer neurodevelopmental outcome, but it is unclear if there is any causal link between these two factors. It also appears that infants who continue to have frequent apnea at the time of their discharge from the NICU are more likely to present with apnea if they develop RSV disease.
1 This appears to demonstrate that there is ongoing respiratory instability in such infants.
The answer given in a recent review article to the question ''Does persistence of apnea, bradycardia, or desaturation in former preterm infants matter?'' was ''maybe''! 23 That answer illuminates the lack of good prospective data with which to determine the size of any potential risks involved. Given the dramatic improvements in survival to hospital discharge of the extremely low-birth-weight infant over the last decade, it is essential that we determine the magnitude and pathogenesis of the risks that they face during the first year or two of life.
